Tag Archives: Suicide

Better Safe than Sorry: Assessing Suicide Risk in Clinical Trials

With the FDA striving to avoid post-market reactions to drugs with worrisome side-effect profiles, preventive measures that screen for obvious risks such as suicidal behavior and abuse potential are making their way into the lexicon of regulators and drug developers alike, in tandem with its mandate that stresses safety first and efficacy a close second. […]
Posted in compliance, FDA, R&D, Regulatory, Safety, Strategy | Also tagged , , , , , , , , | 2 Comments

Antiepileptic Drugs To List Suicidality Warnings

Makers of antiepileptic are now required to include a warning that the drugs could boost thoughts of suicide, according to an FDA statement released yesterday. Drugmakers also must create a risk mitigation strategy for each drug and handout a pamphlet to patients spelling out the potential adverse reactions. “Patients being treated with antiepileptic drugs for […]
Posted in Safety | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta